CTOs on the Move

Epocrates

www.epocrates.com

 
Epocrates, Inc. is a provider of clinical information and decision support tools to healthcare professionals, as well as interactive information services to the healthcare industry. As of April 17, 2008, the Company has subscriber base of over 500,000
  • Number of Employees: 250-1000
  • Annual Revenue: > $1 Billion
  • www.epocrates.com
  • 311 Arsenal Street Watertown
    San Mateo, MA USA 02472
  • Phone: 888.807.2076

Executives

Name Title Contact Details

Similar Companies

Mabis DMI Healthcare

Mabis DMI Healthcare is a Waukegan, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WOMBA

Today, with literally thousands of sports apps, medical apps, nutritional apps and of course doctors` offices and hospitals offering online access to your medical records the chances of anyone checking all their vitals, nutritional intake etc. is close to nil… Why? Way too much data!! WoMBA takes all your data sources and aggregates it under one platform. Aggregated data allows you to see a full picture of your health and gives you a full profile of your E-DNA. Not only does utilizing WoMBA give you easy access to your collected data but many insurance companies will give you a discount for using services such as WoMBA and last but not list, if not the most important, WoMBA can save your life.

Maxtec.

Maxtec. is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endogun Medical Syatems

Endogun Medical Syatems is a Westwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

StimGuard

StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard`s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urology care management.